Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.

Ferch U, Kloo B, Gewies A, Pfänder V, Düwel M, Peschel C, Krappmann D, Ruland J.

J Exp Med. 2009 Oct 26;206(11):2313-20. doi: 10.1084/jem.20091167. Epub 2009 Oct 19. Erratum in: J Exp Med. 2009 Nov 23;206(12):2851.

PMID:
19841089
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.

Lin X, Wang D.

Semin Immunol. 2004 Dec;16(6):429-35. Review.

PMID:
15541657
[PubMed - indexed for MEDLINE]
3.

NF-kappaB signaling in lymphocytes: a new cast of characters.

Lucas PC, McAllister-Lucas LM, Nunez G.

J Cell Sci. 2004 Jan 1;117(Pt 1):31-9. Review.

PMID:
14657271
[PubMed - indexed for MEDLINE]
Free Article
4.

Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Kingeter LM, Schaefer BC.

Cell Signal. 2010 Jan;22(1):9-22. doi: 10.1016/j.cellsig.2009.09.033. Epub 2009 Sep 19. Review.

PMID:
19772915
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1.

Thome M, Tschopp J.

Trends Immunol. 2003 Aug;24(8):419-24. Review. No abstract available.

PMID:
12909454
[PubMed - indexed for MEDLINE]
6.

Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.

Pavan A, Spina M, Canzonieri V, Sansonno S, Toffoli G, De Re V.

Leuk Lymphoma. 2008 Nov;49(11):2048-58. doi: 10.1080/10428190802444176. Review.

PMID:
19021048
[PubMed - indexed for MEDLINE]
7.

Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.

Hosokawa Y.

Apoptosis. 2005 Jan;10(1):25-34. Review.

PMID:
15711920
[PubMed - indexed for MEDLINE]
8.

The Bcl10/Malt1 signaling pathway as a drug target in lymphoma.

Jost P, Peschel C, Ruland J.

Curr Drug Targets. 2006 Oct;7(10):1335-40. Review.

PMID:
17073595
[PubMed - indexed for MEDLINE]
9.

Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.

Bunnell SC.

Mol Interv. 2002 Oct;2(6):356-60, 338. Review.

PMID:
14993411
[PubMed - indexed for MEDLINE]
10.

Protease activity of MALT1: a mystery unravelled.

Kirchhofer D, Vucic D.

Biochem J. 2012 Jun 1;444(2):e3-5. doi: 10.1042/BJ20120414. Review.

PMID:
22574776
[PubMed - indexed for MEDLINE]
11.

MALT1 protease: a new therapeutic target in B lymphoma and beyond?

McAllister-Lucas LM, Baens M, Lucas PC.

Clin Cancer Res. 2011 Nov 1;17(21):6623-31. doi: 10.1158/1078-0432.CCR-11-0467. Epub 2011 Aug 25. Review.

PMID:
21868762
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.

Thome M, Charton JE, Pelzer C, Hailfinger S.

Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a003004. doi: 10.1101/cshperspect.a003004. Epub 2010 Aug 4. Review.

PMID:
20685844
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Gene expression profiling of diffuse large B-cell lymphoma.

Rosenwald A, Staudt LM.

Leuk Lymphoma. 2003;44 Suppl 3:S41-7. Review.

PMID:
15202524
[PubMed - indexed for MEDLINE]
14.

NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Blonska M, Lin X.

Cell Res. 2011 Jan;21(1):55-70. doi: 10.1038/cr.2010.182. Epub 2010 Dec 28. Review.

PMID:
21187856
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

From MALT lymphoma to the CBM signalosome: three decades of discovery.

Rosebeck S, Rehman AO, Lucas PC, McAllister-Lucas LM.

Cell Cycle. 2011 Aug 1;10(15):2485-96. Epub 2011 Aug 1. Review.

PMID:
21750409
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Regulation of NF-κB signaling by caspases and MALT1 paracaspase.

Staal J, Bekaert T, Beyaert R.

Cell Res. 2011 Jan;21(1):40-54. doi: 10.1038/cr.2010.168. Epub 2010 Nov 30. Review.

PMID:
21119681
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Oncogenic activation of NF-kappaB.

Staudt LM.

Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a000109. doi: 10.1101/cshperspect.a000109. Epub 2010 Apr 21. Review.

PMID:
20516126
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Lim KH, Yang Y, Staudt LM.

Immunol Rev. 2012 Mar;246(1):359-78. doi: 10.1111/j.1600-065X.2012.01105.x. Review.

PMID:
22435566
[PubMed - indexed for MEDLINE]
19.

Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

Barton S, Hawkes EA, Wotherspoon A, Cunningham D.

Oncologist. 2012;17(12):1562-73. doi: 10.1634/theoncologist.2012-0218. Epub 2012 Oct 18. Review.

PMID:
23086691
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma.

Sweetenham JW.

Curr Opin Hematol. 2011 Jul;18(4):288-92. doi: 10.1097/MOH.0b013e32834706ee. Review.

PMID:
21519244
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk